FDA Approves Phase I Clinical Trial for SKCC Breast Cancer Vaccine

SAN DIEGO--(BUSINESS WIRE)--The Federal Drug Administration announced Friday approval of a Phase 1 clinical trial designed to study a breast cancer vaccine developed at the Sidney Kimmel Cancer Center (http://www.skcc.org).

MORE ON THIS TOPIC